Founded in White Plains, New York, in 2023, Spectrum Vascular makes vascular-access and medication-management devices for clinical care. Its portfolio expanded through the acquisition of Cook Medical’s vascular-access business in 2023 and AngioDynamics’ PICC, midline, and tip-location products in 2024. The company combines established catheter technologies with newer tools such as its SV NAV+ real-time guidance platform, while emphasizing infection prevention in product design.
Access for LifeFounded by Yale-trained vascular surgeon Dr. Roger Mason, Access for Life is developing a patented, sensor-equipped implantable device for vascular access during hemodialysis. The venture-backed medical-device start-up combines vascular and renal clinical expertise with engineering and business leadership, and its technology is currently undergoing in-vivo trials. Its development history includes a 2019 KidneyX Redesign Dialysis Phase 1 win and a 2022 short in-vivo trial at Mount Sinai.FLEETWOOD, NY
Kaneka Medical America LLCKaneka Medical America develops and manufactures neurovascular medical devices, including the i-ED Coil System for endovascular embolization and the WaveSelect guidewire for navigating complex anatomy. A U.S. subsidiary of Kaneka Americas Holding, it works with Kaneka Corporation in Japan, which commercialized Japan’s first neurovascular embolization coil in 2002. The company operates from New York City with research and development in California and entered the U.S. market in 2021.NEW YORK, NY
AccuVein, IncAccuVein develops near-infrared, laser-based vein visualization systems that project real-time images of superficial veins, valves, and bifurcations to guide vascular access and aesthetic procedures. Based in Medford, New York, the company’s patented True Center™ technology keeps its devices permanently aligned without user calibration, helping clinicians see the vein centerline with each use. AccuVein also emphasizes healthcare equity, highlighting technology designed to provide consistent vein images across skin tones.MEDFORD, NY
AngioDynamicsFounded in Queensbury in 1988, AngioDynamics develops and manufactures medical devices for minimally invasive diagnosis and treatment of cancer and peripheral vascular disease. Its global portfolio includes technologies such as the NanoKnife system for electrical tumor ablation and the Auryon system for peripheral artery disease, supported by manufacturing facilities in New York and worldwide operations. The company is a NASDAQ-listed public company serving physicians through direct sales and distribution partners.QUEENSBURY, NY